Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus

  • Dwi Setyowati Karolina,
  • Arunmozhiarasi Armugam,
  • Subramaniam Tavintharan,
  • Michael T. K. Wong,
  • Su Chi Lim,
  • Chee Fang Sum,
  • Kandiah Jeyaseelan

Correction: MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus

  • Dwi Setyowati Karolina, 
  • Arunmozhiarasi Armugam, 
  • Subramaniam Tavintharan, 
  • Michael T. K. Wong, 
  • Su Chi Lim, 
  • Chee Fang Sum, 
  • Kandiah Jeyaseelan
PLOS
x

The authors would like to state a misinterpretation of the findings of Professor Timmons and his coworkers in Reference 61 [Gallagher et al 2010. Genome Med. 2(2):9]. The authors wish to add: "A separate miRNA profiling study by Gallagher et al [61] using muscle tissue biopsies of impaired glucose tolerance (IGT) and T2D individuals showed 62 dysregulated miRNAs of which miR-144, miR-106b, miR-142-3p, miR-185, miR-451, miR-589, miR-665, miR-668, miR-126*, miR-199a-3p, miR-208a, miR-30e, miR-331-3p, miR-342-3p, miR-374a and miR-374b showed similar expression pattern as observed in our human/animal model studies. Moreover, miR-144 was also found to be highly up-regulated (with a fold change of 2.6) in their T2D samples."